Pfizer and Eli Lilly could have a multibillion-dollar opportunity on their hands with a potential replacement for opioids in treating pain, an analyst says. The drug is called tanezumab.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,